drugmakers all news related to

Drugmakers raised prices on 250+ medicines in the US starting Jan. 1

January 03, 2025

Drugmakers plan to raise US prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol Myers Squibb's cancer cell therapies and vaccines from France's Sanofi at the start of 2025, according to data analyzed by healthcare research firm 3 Axis Advisors.

Drugmakers agree to halve prices to secure access to China

December 28, 2020

Drugmakers from AstraZeneca Plc and GlaxoSmithKline Plc to BeiGene Ltd. agreed to cut prices on some of their newest drugs in China by an average of 51% to be covered by the country's national insurance fund.

Food, drugmakers seen winners in Jokowi's $185 billion budget

SATURDAY, AUGUST 15, 2020

Indonesian drugmakers and consumer goods companies are seen as winners from President Joko Widodo's pledge to lift government spending to a record next year to contain the coronavirus outbreak and revive economic growth.

Administration makes it easier for drugmakers to profit from publicly funded coronavirus drugs, critics say

THURSDAY, JULY 02, 2020

WASHINGTON - The Trump administration is weakening taxpayer safeguards in its agreements with companies working on novel-coronavirus drugs, which could prevent regulators from curbing prices for future vaccines and treatment, a consumer group said Wednesday.

Moderna partner brings production muscle to covid battle

THURSDAY, MAY 21, 2020

Drugmakers racing to make covid-19 vaccines and therapies are seeking out specialized manufacturers like Moderna's partner Lonza Group that can scale up production to billions of doses needed to supply the world.

More problems found in Chinese-made heart medications

MONDAY, AUGUST 06, 2018

Shanghai - Two more Chinese drugmakers have announced that a blood-pressure medication they exported to Taiwan contained a potentially cancer-causing impurity, a month after the same problem at another Chinese manufacturer prompted a global recall.